Pharmaceutical company in
Lugano
77 companies in Pharmaceutical company based in Lugano — name and year of registration from the commercial register.
50 of 77 companies
Kamfarma SA
Since 1978 · 11–20 empl.
Kamfarma SA is a pharmaceutical company involved in the development of medicines and active pharmaceutical ingredients. Its activities include developing API synthesis processes and finished dosage forms, as well as managing projects for pharmaceutical production facilities.
Fordras SA
Since 1983 · 101–500 empl.
Fordras SA is Bioseutica Group’s commercial branch for pharmaceutical ingredients, serving the pharmaceutical and food industries. It produces and distributes products including enzymes such as lysozyme, and conducts research and development into biological products and their applications.
Chemo Project SA
Since 1984 · 21–50 empl.
The core activity of Insud Pharma is the development, manufacture and marketing of pharmaceutical products. The company operates in the healthcare sector and offers innovative solutions for healthcare. The core activities include research and development (15 research and development centers), production (20 industrial facilities) and distribution of medicines.
Altergon SA
Since 1985 · 1–10 empl.
Refarmed Chemicals SA
Since 1995 · 21–50 empl.
The core activity of Refarmed Chemicals Ltd. is the distribution of pharmaceutical active ingredients (Active Pharmaceutical Ingredients, API) and finished dosage forms (Finished Dosage Form, FDF) for the generic pharmaceutical industry.
NANONICA SA
Since 2006 · 1–10 empl.
NANONICA SA facilitates the transfer of knowledge from academia to industry in nanotechnology and microtechnology. It develops and commercializes research results, with applications including medicine, energy and environmental science.
CHEMO AG, Vienna, Lugano Branch
Since 2006 · 1–10 empl.
CHEMO AG, Vienna, Lugano Branch operates in the pharmaceutical sector as part of Insud Pharma’s Chemo industrial business. Chemo researches, develops and manufactures active pharmaceutical ingredients and finished dosage forms for human and veterinary use, and provides contract manufacturing services.
CoreQuest Sagl
Since 2008 · 1–10 empl.
CoreQuest Sagl is a pharmaceutical company that researches and develops medicines and medical devices for nephrology and surgery. Its activities include solutions for peritoneal dialysis and the development of a therapeutic platform for congestive heart failure.
Swiss Applied Coating Research (S.A.C.R.) GmbH
Since 2011 · 1–10 empl.
Swiss Applied Coating Research (S.A.C.R.) GmbH develops and produces solid oral dosage forms for the pharmaceutical, nutraceutical and food industries, with a focus on film coating using natural polymers. Its services also include consultancy, tailored coating formulations, technical support and maintenance for coating equipment.
MABXIENCE SA
Since 2012 · 101–500 empl.
MABXIENCE SA develops and manufactures biopharmaceutical medicines, including biosimilars. It also provides integrated contract development and manufacturing services (CDMO) for biologics.
ADIENNE SA
Since 2012 · 21–50 empl.
ADIENNE SA is a biopharmaceutical company that develops and markets medicines for rare and severe diseases. It also provides contract development and manufacturing services for pharmaceutical products, including analytical and formulation development, process development and commercial manufacturing.
Cures Healthcare Ltd
Since 2012 · 11–20 empl.
Cures Healthcare Ltd is a specialty-branded pharmaceutical company offering project solutions, including technology-transfer projects with international partners. Its activities include pharmaceutical product registration, market entry and marketing, and it offers medicines for export.
Seegpharm SA
Since 2012 · 1–10 empl.
Seegpharm SA co-develops complex generic medicines with partners and out-licenses these products. Its activities also include developing synthesis routes for active ingredients and finished dosage forms, as well as promoting and distributing selected patented products.
Fondazione Ceschina
Since 2013 · 1–10 empl.
Fondazione Ceschina supports scientific and clinical research into rare diseases, with particular attention to immune-mediated inflammatory conditions such as spondyloarthropathies. It funds academic research projects and organizes scientific meetings.
H.E. ADVANCED NUTRITION SA
Since 2013 · 11–20 empl.
The core activity of HE Advanced Nutrition SA is the research and production of nutraceutical and pharmaceutical products, particularly food supplements and medicines, with innovative formulations and the highest quality standards.
ADIENNE Pharma & Biotech SA
Since 2013 · 101–500 empl.
ADIENNE Pharma & Biotech SA develops and markets medicines for rare and severe diseases, with a focus on haematological and immunological conditions. It also provides pharmaceutical development and manufacturing services, including for sterile medicines and biologics.
GT Gain Therapeutics SA
Since 2017 · 11–20 empl.
GT Gain Therapeutics SA develops small-molecule allosteric therapies for neurodegenerative diseases and rare genetic disorders. Its Magellan platform combines AI-supported structural biology with physics-based models for drug discovery, and its candidate rexaceract is being clinically evaluated for Parkinson’s disease.
PROBIONOVA SA
Since 2018 · 11–20 empl.
PROBIONOVA SA conducts research and development on probiotic applications for human health. It produces individual probiotic strains and premixes, and supports the development of probiotic products from concept and validation through to production.
VRFD SA
Since 2020 · 1–10 empl.
VRFD SA develops and sells skincare cosmetics under the Verdilab brand. Its range includes natural skincare products and professional dermo protocols for different skin needs.
KOLINPHARMA SUISSE SA
Since 2021 · 1–10 empl.
KOLINPHARMA SUISSE SA is a company that develops, manufactures and markets nutraceutical health products and dietary supplements. Its product range includes lines for neurological, uro‑gynecological, musculoskeletal and immune support.
KeyBioscience SA
Since 2012 · 11–20 empl.
KeyBioscience SA is a biotechnology company focused on the discovery and development of fully human monoclonal antibodies for the prevention and treatment of serious bacterial and viral infections in the hospital setting. It applies the MabIgX® technology to generate and select fully human monoclonal antibodies and is developing candidates such as KBRV201 targeting respiratory syncytial virus (RSV).
Probiotical Swiss SA
Since 2013 · 1–10 empl.
ROSE PHARMA SA
Since 2007 · 101–500 empl.3.0(2)
ROSE PHARMA SA offers hyaluronic acid-based products for aesthetic and medical applications. Its range includes fillers for facial and gynecological treatments and a hyaluronic acid solution for intra-articular use; the company also provides training and educational resources for healthcare professionals.
Vivendo Pharma GmbH
Since 2020 · 1–10 empl.
Vivendo Pharma GmbH develops and licenses pharmaceutical dossiers and manages related intellectual property rights. Its activities include consultancy, regulatory support and business development; it does not sell or distribute finished pharmaceutical products.
TILAB SWISS Sagl
Since 2020 · 11–20 empl.
TILAB SWISS Sagl distributes cosmetics and personal-care products, food supplements and other health products. Its range includes creams, gels, sprays, capsules and intimate-care products.
Contrad Swiss SA
Since 2011 · 11–20 empl.4.7(3)
Contrad Swiss SA develops pharmaceutical products and medical devices for regenerative medicine. Its portfolio includes topical formulations for musculoskeletal conditions and products to support skin recovery after aesthetic procedures.
Healiva SA
Since 2020 · 1–10 empl.
Healiva SA is a biotechnology company developing personalized therapies for chronic wounds. Its approach combines cell therapies, enzyme technology and medical devices.
OmniCap GmbH
Since 2011 · 11–20 empl.5.0(3)
OmniCap GmbH provides advisory and trading services for the pharmaceutical, cosmetics and food industries. It distributes products including active pharmaceutical ingredients, excipients and other raw materials, and supports companies with international trade, sourcing and logistics.
InkVivo Technologies SA
Since 2023 · 11–20 empl.
InkVivo Technologies SA develops polymer-based drug delivery platforms for pharmaceutical and nutraceutical applications. Its solutions enable controlled, localized and sustained release of active ingredients through oral and injectable routes.
In Virtuo Laboratories SA
Since 2024 · 1–10 empl.
In Virtuo Laboratories SA develops a platform that combines artificial intelligence and physics-based molecular simulations to identify and optimize drug candidates.
EXERIS BIO SA
Since 2023 · 1–10 empl.
EXERIS BIO SA provides custom solutions for the manufacturing of small molecules and recombinant proteins. The company also operates as a sales agency and chemical distributor representing custom chemical manufacturers.
DEVINTEC Sagl
Since 2017 · 1–10 empl.5.0(1)
DEVINTEC Sagl develops and commercializes healthcare products and medical devices based on DevinPro™ technology, which combines natural polysaccharides and proteins. Its therapeutic areas include gastroenterology, dermatology and women’s health, with activities spanning research, clinical validation and market launch.
Crystal Hemp SA
Since 2016 · 11–20 empl.5.0(1)
Crystal Hemp SA develops and distributes cannabinoid-based products for pharmaceutical and cosmetic applications. Its range includes natural and synthetic CBD active pharmaceutical ingredients certified to GMP standards, as well as CBD-based dermatological products.
Advitech Consulting SA
Since 2024 · 1–10 empl.
Advitech Consulting SA is an advisory firm serving the healthcare and fine chemicals industries. It provides corporate development, management consulting and business intelligence services, supports mergers and acquisitions, and selects and develops products and technologies for its own portfolio.
GAMMADIS FARMACEUTICI S.R.L., Civitanova Marche, succursale di Lugano
1–10 empl.
GAMMADIS FARMACEUTICI S.R.L., Civitanova Marche, succursale di Lugano operates in the pharmaceutical market, producing and distributing medical devices and healthcare products. Its own brands include products for pharmacies and hospitals.
Bio API SA
Since 2010 · 1–10 empl.
Viva SA
Since 1942 · 1–10 empl.
Siphar SA
Since 1963 · 1–10 empl.
Nutro SA
Since 1972 · 1–10 empl.
FARMACEUTICA TEOFARMA SUISSE SA
Since 2005 · 1–10 empl.
Quolibet SA
Since 2005 · 1–10 empl.
EAS Tibia Swiss SA
Since 2006 · 1–10 empl.
Novintethical Pharma SA
Since 2009 · 1–10 empl.
Lab Dom (Suisse) SA
Since 2010 · 1–10 empl.
SWC SWiSS WELLNESS CENTER SA
Since 2011 · 1–10 empl.
Fermentazione Microbiologica AG
Since 2012 · 1–10 empl.
HOLOS PHARM Sagl
Since 2012 · 1–10 empl.
FitoAMico SA
Since 2012 · 1–10 empl.
Genecta Pharmaceuticals Sagl
Since 2013 · 1–10 empl.
IM-TT INTERNATIONAL MEDI-TECH TRADE SA
Since 2013 · 1–10 empl.
Pharmaceutical company in Lugano
Pharmaceutical company in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of November 7, 2026
Pharmaceutical company in other places
By canton